These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 26523483)

  • 1. Golimumab for the treatment of axial spondyloarthritis.
    Gelfer G; Perry L; Deodhar A
    Expert Rev Clin Immunol; 2016; 12(1):9-18. PubMed ID: 26523483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An appraisal of golimumab in the treatment of severe, active nonradiographic axial spondyloarthritis.
    Paccou J; Flipo RM
    Drug Des Devel Ther; 2016; 10():2255-62. PubMed ID: 27468228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Golimumab for treatment of axial spondyloarthritis.
    Rios Rodriguez V; Poddubnyy D
    Immunotherapy; 2016 Feb; 8(2):107-15. PubMed ID: 26798943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trials.
    Toussirot E; Vauchy C; Binda D; Michel F
    Drug Des Devel Ther; 2016; 10():2087-94. PubMed ID: 27445459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on the use of tumor necrosis factor alpha inhibitors in the treatment of ankylosing spondylitis.
    Osman MS; Maksymowych WP
    Expert Rev Clin Immunol; 2017 Feb; 13(2):125-131. PubMed ID: 27479149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis.
    Callhoff J; Sieper J; Weiß A; Zink A; Listing J
    Ann Rheum Dis; 2015 Jun; 74(6):1241-8. PubMed ID: 24718959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients--baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practice.
    Wallman JK; Kapetanovic MC; Petersson IF; Geborek P; Kristensen LE
    Arthritis Res Ther; 2015 Dec; 17():378. PubMed ID: 26703005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Necrosis Factor-α Inhibition in Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Treatment Response, Drug Survival, and Patient Outcome.
    Corli J; Flipo RM; Philippe P; Bera-Louville A; Béhal H; Wibaux C; Paccou J
    J Rheumatol; 2015 Dec; 42(12):2376-82. PubMed ID: 26568593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Certolizumab pegol for treating axial spondyloarthritis.
    Desmarais J; Beier S; Deodhar A
    Expert Opin Biol Ther; 2016 Aug; 16(8):1059-64. PubMed ID: 27366922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis.
    Deodhar A; Strand V; Kay J; Braun J
    Ann Rheum Dis; 2016 May; 75(5):791-4. PubMed ID: 26768406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should axial spondyloarthritis without radiographic changes be treated with anti-TNF agents?
    Keat A; Bennett AN; Gaffney K; Marzo-Ortega H; Sengupta R; Everiss T
    Rheumatol Int; 2017 Mar; 37(3):327-336. PubMed ID: 28035438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-α drugs: an Italian multicenter study.
    Lubrano E; Perrotta FM; Marchesoni A; D'Angelo S; Ramonda R; Addimanda O; Olivieri I; Punzi L; Salvarani C
    J Rheumatol; 2015 Feb; 42(2):258-63. PubMed ID: 25512483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.
    Malaviya AN; Kalyani A; Rawat R; Gogia SB
    Int J Rheum Dis; 2015 Sep; 18(7):736-41. PubMed ID: 26172961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor efficacy of TNF inhibitors in non-radiographic axial spondyloarthritis in the absence of objective signs: A bicentric retrospective study.
    Vidal C; Lukas C; Combe B; Berenbaum F; Pers YM; Jorgensen C; Sellam J; Morel J
    Joint Bone Spine; 2018 Jul; 85(4):461-468. PubMed ID: 28917996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Golimumab for the treatment of axial spondyloarthritis.
    Palazzi C; D'angelo S; Gilio M; Leccese P; Padula A; Olivieri I
    Expert Opin Biol Ther; 2017 Jan; 17(1):129-133. PubMed ID: 27817204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial review: how early should ankylosing spondylitis be treated with a tumor necrosis factor-blocker?
    Haibel H; Sieper J
    Curr Opin Rheumatol; 2010 Jul; 22(4):388-92. PubMed ID: 20473176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor alpha antagonists in the treatment of axial spondyloarthritis.
    Braun J; Baraliakos X; Heldmann F; Kiltz U
    Expert Opin Investig Drugs; 2014 May; 23(5):647-59. PubMed ID: 24654630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Certolizumab pegol in axial spondyloarthritis.
    Song IH; Rudwaleit M
    Expert Rev Clin Immunol; 2013 Dec; 9(12):1161-72. PubMed ID: 24215406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?
    Kiltz U; Baraliakos X; Karakostas P; Igelmann M; Kalthoff L; Klink C; Krause D; Schmitz-Bortz E; Flörecke M; Bollow M; Braun J
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1415-22. PubMed ID: 22505331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secukinumab in axial spondyloarthritis: a narrative review of clinical evidence.
    Braun J; Kiltz U; Bühring B; Baraliakos X
    Ther Adv Musculoskelet Dis; 2021; 13():1759720X211041854. PubMed ID: 34471428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.